/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2014-11-26 16:24:562021-01-07 12:22:16Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl−/− mice by administration of soluble (non-targeted) chimeric alkaline phosphatase
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2014-02-24 16:45:172021-01-07 12:22:21Catalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2013-01-01 16:48:482021-01-07 12:22:27Alkaline Phosphatase as a Treatment of Sepsis-Associated Acute Kidney Injury
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2012-11-06 16:38:372021-01-07 12:22:31Alkaline phosphatase as a treatment for sepsis-associated acute kidney injury
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2012-02-14 16:48:322021-01-07 12:22:38Alkaline phosphatase in sepsis-induced AKI
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
0
0
Info
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png
Info2012-01-23 17:00:352021-01-07 12:22:43Alkaline phosphatase for treatment of sepsisinduced acute kidney injury: a prospective randomized double-blind placebo-controlled trial